mifepristone has been researched along with pregnanediol in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (40.00) | 18.7374 |
| 1990's | 3 (60.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Baird, DT; Hillier, H; Ledger, WL; Sweeting, VM | 1 |
| Baird, DT; Dewar, M; Glasier, A; Mackie, M; Thong, KJ | 1 |
| Bygdeman, M; Daniore, V; de la Torre, B; Johannisson, E; Swahn, ML | 1 |
| Croxatto, HB; Romero, C; Salvatierra, AM; Spitz, IM | 1 |
| Bygdeman, M; Danielsson, KG; Johannisson, E; Seppälä, M; Swahn, ML; Westlund, P | 1 |
1 trial(s) available for mifepristone and pregnanediol
| Article | Year |
|---|---|
Mifepristone (RU 486) compared with high-dose estrogen and progestogen for emergency postcoital contraception.
Topics: Adolescent; Adult; Contraceptives, Postcoital, Hormonal; Emergencies; Ethinyl Estradiol; Female; Humans; Menstruation; Middle Aged; Mifepristone; Norgestrel; Pregnancy; Pregnancy, Unwanted; Pregnanediol; Progesterone; Random Allocation | 1992 |
4 other study(ies) available for mifepristone and pregnanediol
| Article | Year |
|---|---|
Inhibition of ovulation by low-dose mifepristone (RU 486).
Topics: Adult; Estrogens, Conjugated (USP); Estrone; Female; Humans; Luteinizing Hormone; Mifepristone; Ovulation; Pituitary Hormones; Pituitary-Adrenal System; Pregnanediol; Steroids | 1992 |
The effect of RU486 administered during the proliferative and secretory phase of the cycle on the bleeding pattern, hormonal parameters and the endometrium.
Topics: Adult; Endometrium; Estrenes; Estrone; Female; Humans; Hydrocortisone; Luteinizing Hormone; Menstrual Cycle; Menstruation; Menstruation-Inducing Agents; Middle Aged; Mifepristone; Pregnanediol | 1988 |
Late luteal phase administration of RU486 for three successive cycles does not disrupt bleeding patterns or ovulation.
Topics: Adult; Estradiol; Estrenes; Estrone; Female; Follicle Stimulating Hormone; Humans; Luteal Phase; Luteinizing Hormone; Menstruation; Mifepristone; Ovulation; Pregnanediol; Progesterone | 1987 |
Effect of low daily doses of mifepristone on ovarian function and endometrial development.
Topics: Adult; Aged; Biopsy; Endometrium; Estrone; Female; Glucuronates; Glycodelin; Glycoproteins; Humans; Hydrocortisone; Immunoenzyme Techniques; Luteinizing Hormone; Middle Aged; Mifepristone; Ovarian Follicle; Ovary; Ovulation; Pregnancy Proteins; Pregnanediol | 1997 |